We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

ALTAPHARMA MARKET ANALYSIS

Altapharma Market, By Product Categories (Vitamins and Minerals, Dietary Supplements, Herbal and Natural Products, Baby and Child Nutrition, Beauty and Skincare Supplements, and Others (Specialty Health Products, Sports Nutrition, among others)), By Application (Immune Support, Bone and Joint Health, Heart Health, Energy and Vitality, Skin and Hair Health, and Others (Cognitive Health, Digestive Health, among others)), By Age Group (Children, Adult, and Geriatric), By Packaging Types (Bottles and Jars, Blister Packs, Sachets and Stick Packs, Liquid Formulations, and Softgels and Capsules), By Packaging Size (Single-Dose Packets, Small Medium and Large Bottles, and Bulk Packs), By Distribution Channel (Supermarkets and Hypermarkets, Pharmacies, E-commerce, Others (Health and Wellness Stores, Specialty Nutrition Stores, among others)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Nov 2023
  • Code : CMI6175
  • Pages :160
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Altapharma MarketSize and Trends

Global Altapharma Market is expected to reach US$ 398.6 Mn by 2030, from US$ 200.8 Mn in 2023, exhibiting a CAGR of 10.3% during the forecast period.

Global Altapharma Market- Trends

  • Shift towards Biopharmaceuticals: Biopharmaceuticals are witnessing rising adoption over conventional drugs owing to their high efficacy and specificity. The trend of increasing focus on biopharmaceuticals has significantly impacted the altapharma market in recent years. Many major pharmaceutical companies that traditionally focused on small-molecule drugs are now actively pursuing opportunities in biologics such as monoclonal antibodies, recombinant proteins, and gene and cell therapies. Biopharmaceuticals often provide targeted treatment options with fewer side effects than conventional drugs.
  • Rise of OTC Medications: Increasing availability and demand for OTC medications such as analgesics, cough/cold products, and others for treatment of minor illnesses is contributing to market growth. Acquisitions in OTC brands have also increased. For instance, in 2022, Johnson & Johnson a pharmaceutical company spent US$ 16.6 billion acquiring Tylenol-maker McNeil Nutritionals, to expand its consumer healthcare segment.
  • Growing Use of Digital Health Solutions: Digital therapeutics, telehealth and mHealth solutions are improving patient engagement, medication adherence and health outcomes. Growing use of digital health solutions is significantly influencing the global altapharma market. This trend allows altapharma brands to market natural medicines and remedies for common minor ailments directly to consumers through such online channels. According to a study by CDC in 2021, the number of digital health users in the U.S. grew from around 25 million in 2016 to over 75 million in 2021. This rapid growth in virtual care presents a significant opportunity for alternative pharmaceutical products and services to reach more patients and form an important part of mainstream medical care delivered through digital means.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.